EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen
S Scheipl, M Barnard, L Cottone… - The Journal of …, 2016 - Wiley Online Library
Chordoma is a rare malignant bone tumour with a poor prognosis and limited therapeutic
options. We undertook a focused compound screen (FCS) against 1097 compounds on …
options. We undertook a focused compound screen (FCS) against 1097 compounds on …
[引用][C] EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen
S Scheipl, M Barnard, L Cottone, M Jorgensen… - 2016 - oparu.uni-ulm.de
[引用][C] EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen
S Scheipl, M Barnard, L Cottone, M Jorgensen… - The Journal of …, 2016 - cir.nii.ac.jp
EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen
| CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
| CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen
S Scheipl, M Barnard, L Cottone… - The Journal of …, 2016 - pubmed.ncbi.nlm.nih.gov
Chordoma is a rare malignant bone tumour with a poor prognosis and limited therapeutic
options. We undertook a focused compound screen (FCS) against 1097 compounds on …
options. We undertook a focused compound screen (FCS) against 1097 compounds on …
EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen
S Scheipl, M Barnard, L Cottone, M Jorgensen… - Journal of …, 2016 - hero.epa.gov
Chordoma is a rare malignant bone tumour with a poor prognosis and limited therapeutic
options. We undertook a focused compound screen (FCS) against 1097 compounds on …
options. We undertook a focused compound screen (FCS) against 1097 compounds on …
EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen: Focused Compound Screen in Chordoma
S Scheipl, M Barnard, L Cottone… - The Journal of …, 2016 - cdr.lib.unc.edu
Chordoma is a rare malignant bone tumour with a poor prognosis and limited therapeutic
options. We undertook a focused compound screen (FCS) against 1097 compounds on …
options. We undertook a focused compound screen (FCS) against 1097 compounds on …
[PDF][PDF] EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen
S Scheipl, M Barnard, L Cottone, M Jorgensen… - J Pathol, 2016 - scienceopen.com
Chordoma is a rare malignant bone tumour with a poor prognosis and limited therapeutic
options. We undertook a focused compound screen (FCS) against 1097 compounds on …
options. We undertook a focused compound screen (FCS) against 1097 compounds on …
EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen
S Scheipl, M Barnard, L Cottone, M Jorgensen… - The Journal of …, 2016 - infona.pl
Chordoma is a rare malignant bone tumour with a poor prognosis and limited therapeutic
options. We undertook a focused compound screen (FCS) against 1097 compounds on …
options. We undertook a focused compound screen (FCS) against 1097 compounds on …
EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen.
S Scheipl, M Barnard, L Cottone, M Jorgensen… - J Pathol, 2016 - discovery.ucl.ac.uk
Chordoma is a rare malignant bone tumour with a poor prognosis and limited therapeutic
options. We undertook a focused compound screen (FCS) against 1097 compounds on …
options. We undertook a focused compound screen (FCS) against 1097 compounds on …
[PDF][PDF] EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen
S Scheipl, M Barnard, L Cottone, M Jorgensen… - J Pathol, 2016 - core.ac.uk
Chordoma is a rare malignant bone tumour with a poor prognosis and limited therapeutic
options. We undertook a focused compound screen (FCS) against 1097 compounds on …
options. We undertook a focused compound screen (FCS) against 1097 compounds on …